 |
|
Epidermal Growth Factor Receptor Mutations in Colorectal Cancer Patients
Bo-Young Oh, Ryung-Ah Lee, Soon-Sup Chung, Kwang Ho Kim
J Korean Soc Coloproctol. 2011;27(3):127-132. Published online 2011 Jun 30 DOI: https://doi.org/10.3393/jksc.2011.27.3.127
|
|
Citations to this article as recorded by
 Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges
Chiara Tramontano, Luca De Stefano, Ilaria Rea
Marine Drugs.2023; 21(5): 266. CrossRef Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of Curcuma longa as Potential Lead Inhibitors of ERBB and VEGFR-2 for the Treatment of Colorectal Cancer
Syeda Abida Ejaz, Mubashir Aziz, Mohamed Fawzy Ramadan, Ammara Fayyaz, Muhammad Sajjad Bilal
Molecules.2023; 28(10): 4044. CrossRef Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings
Dylan Haynes, Eric E. Morgan, Emily Y. Chu
Human Pathology.2023; 140: 129. CrossRef Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response
Tae Hoon Lee, Bum‐Sup Jang, Ji Hyun Chang, Eunji Kim, Jeong Hwan Park, Eui Kyu Chie
Cancer Medicine.2023; 12(14): 15664. CrossRef Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives
Joao Manzi, Camilla O. Hoff, Raphaella Ferreira, Agustin Pimentel, Jashodeep Datta, Alan S. Livingstone, Rodrigo Vianna, Phillipe Abreu
Cancers.2023; 15(11): 3023. CrossRef NRAS mutant E132K identified in young-onset sporadic colorectal cancer and the canonical mutants G12D and Q61K affect distinct oncogenic phenotypes
Ryan Timothy D. Yu, Reynaldo L. Garcia
Scientific Reports.2020;[Epub] CrossRef Predicting Response to Neoadjuvant Therapy in Colorectal Cancer Patients the Role of Messenger-and Micro-RNA Profiling
Alberto Izzotti, Chiara Ceccaroli, Marta Geretto, Filippo Grillo Ruggieri, Sara Schenone, Emilio Di Maria
Cancers.2020; 12(6): 1652. CrossRef Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
Marcel Wiesweg, Stefan Kasper, Karl Worm, Thomas Herold, Henning Reis, Linda Sara, Martin Metzenmacher, Annalena Abendroth, Kaid Darwiche, Clemens Aigner, Heiner H. Wedemeyer, Fabian A. Helfritz, Martin Stuschke, Brigitte Schumacher, Peter Markus, Andreas
Oncogene.2019; 38(16): 2953. CrossRef Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer
Evangelos Koustas, Michalis V. Karamouzis, Chrysovalantou Mihailidou, Dimitrios Schizas, Athanasios G. Papavassiliou
Cancer Letters.2017; 396: 94. CrossRef Lack of Mutations in Protein Tyrosine Kinase Domain Coding Exons 19 and 21 of the EGFR Gene in Oral Squamous Cell Carcinomas
Dhaval Tushar Mehta, Thangavelu Annamalai, Arvind Ramanathan
Asian Pacific Journal of Cancer Prevention.2014; 15(11): 4623. CrossRef Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis
Shoude Zhang, Jia Chen, Hua Jiang, Haina Ma, Beibei Yang
European Journal of Clinical Pharmacology.2012; 68(5): 561. CrossRef Are Mutations of the EGFR Gene Promising Predictive Markers for Anti-EGFR mAbs in Colorectal Carcinomas?
Dong-Guk Park
Journal of the Korean Society of Coloproctology.2011; 27(3): 103. CrossRef
|